Pneumococcal Vaccines Market Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2017 - 2026
Report Highlights
Global Pneumococcal Vaccines Market- Overview
The prevention of disease through vaccination is one of the most cost-effective and safe ways. Pneumococcus is one of the leading causes of blood infection, pneumonia, sinusitis, meningitis, and otitis media. It is also one of the leading infectious diseases. However, it can be prevented with the help of vaccination. With an increase in pneumococcal disease due to causative serotype, the need for vaccines with broader coverage has increased. Hence, the demand for new pneumococcal vaccines with broader serotype coverage is increasing.
Despite the availability of antibiotic therapy against pneumococcal disease, it remains a significant cause of death among people with increased susceptibility, such as older adults and also the people suffering from immunosuppressive conditions or chronic illness. However, reduction in the pneumococcal disease has been witnessed in the countries that introduced pneumococcal conjugate vaccines (PCV). Meanwhile, efforts are underway to introduce pneumococcal vaccines in other countries as well. Companies are also working on introducing new and affordable PCVs, especially for developing countries. There has also been an increase in investment in the research and development activities to develop new vaccines at lower cost.
Global Pneumococcal Vaccines Market – Scope of Study
The research report on the global pneumococcal vaccines market offers key market insights and factors playing an important role in the market growth. The report provides information on market dynamics including trends, factors driving the market, opportunities, and restraints. Key developments in the market are also provided in the report. The report also offers analysis and forecast on various market segments and regions.
The report offers detailed study on the present and upcoming opportunities and developments along with advancement in technologies. Porter’s five force model along with SWOT analysis is also given in the report. The report has also evaluated market attractiveness. The global pneumococcal vaccines market displays the revenue, market share, growth rate for segments as well as regions.
The primary and secondary research has been done to offer both quantitative and qualitative data. The detail on leading players operating in the market along with the business strategies and new developments has also been provided in the report. Also covered in the report are regulations, ongoing research and developments in various countries. This will help the companies to make important business decisions to strengthen their position in the market.
Global Pneumococcal Vaccines Market- Key Segments
The global pneumococcal vaccines market is divided into product type, distribution channel, and region. Product type is further segmented into 7- valent PCV, 10- valent PCV, 13- valent PCV, and 23- valent PPSV. On the basis of distribution channel, the market is segmented into hospitals, clinics, and other distribution channels.
Region-wise, the market is segmented into Europe, Japan, Latin America, North America, Asia Pacific Excluding Japan (APEJ), and the Middle East and Africa (MEA). This segmentation also offers country-wise analysis on all the key parameters associated with the global pneumococcal vaccines market.
Global Pneumococcal Vaccines Market- Competitive Landscape
The report offers competitive landscape including vital information on some of the leading players contributing towards the market expansion. Some of the leading players operating in the market are Pfizer, Inc., GlaxoSmithKline PLC, Merck & Co. Inc., and Sanofi. The report offers detailed profile on each of the players including company overview, key strategies, financial overview, latest developments, and product portfolio.
- Table 1 : Global Pneumococcal Vaccines Market Value (US$ Mn), 2012-2017
- Table 2 : Global Pneumococcal Vaccines Market Value (US$ Mn), 2018-2026
- Table 3 : Global Pneumococcal Vaccines Market Value (US$ Mn) and Y-o-Y, 2017-2026
- Table 4 : Global 7- Valent PCV Segment Value (US$ Mn), By Region 2012-2017
- Table 5 : Global 7- Valent PCV Segment Value (US$ Mn), By Region 2018-2026
- Table 6 : Global 7- Valent PCV Segment Market Share, By Region 2012-2017
- Table 7 : Global 7- Valent PCV Segment Market Share, By Region 2018-2026
- Table 8 : Global 7- Valent PCV Segment Y-o-Y, By Region 2017-2026
- Table 9 : Global 10- Valent PCV Segment Value (US$ Mn), By Region 2012-2017
- Table 10 : Global 10- Valent PCV Segment Value (US$ Mn), By Region 2018-2026
- Table 11 : Global 10- Valent PCV Segment Market Share, By Region 2012-2017
- Table 12 : Global 10- Valent PCV Segment Market Share, By Region 2018-2026
- Table 13 : Global 10- Valent PCV Segment Y-o-Y, By Region 2017-2026
- Table 14 : Global 13- Valent PCV Segment Value (US$ Mn), By Region 2012-2017
- Table 15 : Global 13- Valent PCV Segment Value (US$ Mn), By Region 2018-2026
- Table 16 : Global 13- Valent PCV Segment Market Share, By Region 2012-2017
- Table 17 : Global 13- Valent PCV Segment Market Share, By Region 2018-2026
- Table 18 : Global 13- Valent PCV Segment Y-o-Y, By Region 2017-2026
- Table 19 : Global 23- Valent PPSV Segment Value (US$ Mn), By Region 2012-2017
- Table 20 : Global 23- Valent PPSV Segment Value (US$ Mn), By Region 2018-2026
- Table 21 : Global 23- Valent PPSV Segment Market Share, By Region 2012-2017
- Table 22 : Global 23- Valent PPSV Segment Market Share, By Region 2018-2026
- Table 23 : Global 23- Valent PPSV Segment Y-o-Y, By Region 2017-2026
- Table 24 : Global Hospitals Segment Value (US$ Mn), By Region 2012-2017
- Table 25 : Global Hospitals Segment Value (US$ Mn), By Region 2018-2026
- Table 26 : Global Hospitals Segment Market Share, By Region 2012-2017
- Table 27 : Global Hospitals Segment Market Share, By Region 2018-2026
- Table 28 : Global Hospitals Segment Y-o-Y, By Region 2017-2026
- Table 29 : Global Clinics Segment Value (US$ Mn), By Region 2012-2017
- Table 30 : Global Clincs Segment Value (US$ Mn), By Region 2018-2026
- Table 31 : Global Clincs Segment Market Share, By Region 2012-2017
- Table 32 : Global Clincs Segment Market Share, By Region 2018-2026
- Table 33 : Global Clincs Segment Y-o-Y, By Region 2017-2026
- Table 34 : Global Other End Users Segment Value (US$ Mn), By Region 2012-2017
- Table 35 : Global Other End Users Segment Value (US$ Mn), By Region 2018-2026
- Table 36 : Global Other End Users Segment Market Share, By Region 2012-2017
- Table 37 : Global Other End Users Segment Market Share, By Region 2018-2026
- Table 38 : Global Other End Users Segment Y-o-Y, By Region 2017-2026
- Table 39 : North America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
- Table 40 : North America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
- Table 41 : North America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
- Table 42 : North America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
- Table 43 : North America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
- Table 44 : North America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
- Table 45 : North America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
- Table 46 : North America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
- Table 47 : North America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
- Table 48 : North America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
- Table 49 : North America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
- Table 50 : Latin America Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
- Table 51 : Latin America Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
- Table 52 : Latin America Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
- Table 53 : Latin America Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
- Table 54 : Latin America Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
- Table 55 : Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
- Table 56 : Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
- Table 57 : Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
- Table 58 : Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
- Table 59 : Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
- Table 60 : Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
- Table 61 : Europe Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
- Table 62 : Europe Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
- Table 63 : Europe Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
- Table 64 : Europe Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
- Table 65 : Europe Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
- Table 66 : Europe Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
- Table 67 : Europe Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
- Table 68 : Europe Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
- Table 69 : Europe Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
- Table 70 : Europe Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
- Table 71 : Europe Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
- Table 72 : Japan Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
- Table 73 : Japan Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
- Table 74 : Japan Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
- Table 75 : Japan Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
- Table 76 : Japan Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
- Table 77 : Japan Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
- Table 78 : Japan Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
- Table 79 : Japan Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
- Table 80 : Japan Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
- Table 81 : Japan Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
- Table 82 : Japan Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
- Table 83 : APEJ Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
- Table 84 : APEJ Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
- Table 85 : APEJ Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
- Table 86 : APEJ Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
- Table 87 : APEJ Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
- Table 88 : APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
- Table 89 : APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
- Table 90 : APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
- Table 91 : APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
- Table 92 : APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
- Table 93 : APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
- Table 94 : MEA Current Expenditure on Health, (% of GDP), by Country, 2010 – 2016
- Table 95 : MEA Per Capita Health Expenditure (US$ PPP), by Country, 2010 - 2016
- Table 96 : MEA Per Capita Healthcare Expenditure Y-o-Y Growth (in Real terms %), by Country, 2010 - 2016
- Table 97 : MEA Out-of-Pocket Healthcare Expenditure, % of Healthcare Expenditure, by Country, 2010 - 2016
- Table 98 : MEA Per Capita Healthcare Expenditure (at Current Price, in US$), by Country, 2010 - 2016
- Table 99 : MEA Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
- Table 100 : MEA Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
- Table 101 : MEA Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
- Table 102 : MEA Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
- Table 103 : MEA Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
- Table 104 : MEA Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
- Figure 1 : Global Pneumococcal Vaccines Market Value (US$ Mn), 2012-2017
- Figure 2 : Global Pneumococcal Vaccines Market Value (US$ Mn) Forecast, 2018-2026
- Figure 3 : Global Pneumococcal Vaccines Market Value (US$ Mn) and Y-o-Y, 2017-2026
- Figure 4 : Global 7- Valent PCV Segment Market Value (US$ Mn) By Region, 2012-2017
- Figure 5 : Global 7- Valent PCV Segment Market Value (US$ Mn) By Region, 2018-2026
- Figure 6 : Global 7- Valent PCV Segment Y-o-Y Growth Rate, By Region, 2017-2026
- Figure 7 : Global 10- Valent PCV Segment Market Value (US$ Mn) By Region, 2012-2017
- Figure 8 : Global 10- Valent PCV Segment Market Value (US$ Mn) By Region, 2018-2026
- Figure 9 : Global 10- Valent PCV Segment Y-o-Y Growth Rate, By Region, 2017-2026
- Figure 10 : Global 13- Valent PCV Segment Market Value (US$ Mn) By Region, 2012-2017
- Figure 11 : Global 13- Valent PCV Segment Market Value (US$ Mn) By Region, 2018-2026
- Figure 12 : Global 13- Valent PCV Segment Y-o-Y Growth Rate, By Region, 2017-2026
- Figure 13 : Global 23- Valent PPSV Segment Market Value (US$ Mn) By Region, 2012-2017
- Figure 14 : Global 23- Valent PPSV Segment Market Value (US$ Mn) By Region, 2018-2026
- Figure 15 : Global 23- Valent PPSV Segment Y-o-Y Growth Rate, By Region, 2017-2026
- Figure 16 : Global Hospitals Segment Market Value (US$ Mn) By Region, 2012-2017
- Figure 17 : Global Hospitals Segment Market Value (US$ Mn) By Region, 2018-2026
- Figure 18 : Global Hospitals Segment Y-o-Y Growth Rate, By Region, 2017-2026
- Figure 19 : Global Clincs Segment Market Value (US$ Mn) By Region, 2012-2017
- Figure 20 : Global Clincs Segment Market Value (US$ Mn) By Region, 2018-2026
- Figure 21 : Global Clincs Segment Y-o-Y Growth Rate, By Region, 2017-2026
- Figure 22 : Global Other End Users Segment Market Value (US$ Mn) By Region, 2012-2017
- Figure 23 : Global Other End Users Segment Market Value (US$ Mn) By Region, 2018-2026
- Figure 24 : Global Other End Users Segment Y-o-Y Growth Rate, By Region, 2017-2026
- Figure 25 : North America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
- Figure 26 : North America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
- Figure 27 : North America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
- Figure 28 : North America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
- Figure 29 : North America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
- Figure 30 : North America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
- Figure 31 : Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
- Figure 32 : Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
- Figure 33 : Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
- Figure 34 : Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
- Figure 35 : Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
- Figure 36 : Latin America Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
- Figure 37 : Europe Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
- Figure 38 : Europe Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
- Figure 39 : Europe Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
- Figure 40 : Europe Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
- Figure 41 : Europe Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
- Figure 42 : Europe Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
- Figure 43 : Japan Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
- Figure 44 : Japan Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
- Figure 45 : Japan Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
- Figure 46 : Japan Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
- Figure 47 : Japan Pneumococcal Vaccines Market Value (US$ Mn), By 2012-2017
- Figure 48 : Japan Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
- Figure 49 : APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
- Figure 50 : APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
- Figure 51 : APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
- Figure 52 : APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
- Figure 53 : APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
- Figure 54 : APEJ Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
- Figure 55 : MEA Pneumococcal Vaccines Market Value (US$ Mn), By Country 2012-2017
- Figure 56 : MEA Pneumococcal Vaccines Market Value (US$ Mn), By Country 2018-2026
- Figure 57 : MEA Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2012-2017
- Figure 58 : MEA Pneumococcal Vaccines Market Value (US$ Mn), By Product Type 2018-2026
- Figure 59 : MEA Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2012-2017
- Figure 60 : MEA Pneumococcal Vaccines Market Value (US$ Mn), By Distribution Channel 2018-2026
Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.